Li, Y.-Z.; Kong, S.-N.; Liu, Y.-P.; Yang, Y.; Zhang, H.-M.
Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC? J. Clin. Med. 2023, 12, 1438.
https://doi.org/10.3390/jcm12041438
AMA Style
Li Y-Z, Kong S-N, Liu Y-P, Yang Y, Zhang H-M.
Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC? Journal of Clinical Medicine. 2023; 12(4):1438.
https://doi.org/10.3390/jcm12041438
Chicago/Turabian Style
Li, Yi-Ze, Sheng-Nan Kong, Yun-Peng Liu, Yue Yang, and Hong-Mei Zhang.
2023. "Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?" Journal of Clinical Medicine 12, no. 4: 1438.
https://doi.org/10.3390/jcm12041438
APA Style
Li, Y.-Z., Kong, S.-N., Liu, Y.-P., Yang, Y., & Zhang, H.-M.
(2023). Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC? Journal of Clinical Medicine, 12(4), 1438.
https://doi.org/10.3390/jcm12041438